Zampilimab, identified as UCB-7858 or 2098280-42-1, represents a novel therapeutic agent targeting TGM2, a molecule involved in fat metabolism and possibly implicated in various autoimmune disorders. This https://www.targetmol.com/compound/zampilimab
Zampilimab: A In-depth Exploration into the TGM2 Immunoglobulin (UCB-7858, 2098280-42-1)
Internet - 2 hours 54 minutes ago zakariajcbr770429
Web Directory Categories
Web Directory Search
New Site Listings